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Effect of coichicine and calcitonin on calcemic response to metabolic
acidosis. To examine the mechanism responsible for enhanced calcium
mobilization from bone in metabolic acidosis, we evaluated the effect of
colchicine and calcitonin, two blockers of cell-mediated bone resorp-
tion, on the calcemic response to acute metabolic acidosis in thyropar-
athyroidectomized rats. Metabolic acidosis lasting 16 hr and induced by
the feeding of NH4CI led to a significant rise in serum calcium of 1.2 to
1.9 mg/dl. The administration of coichicine or calcitonin led to a
decrement in serum calcium of 1.1 0.2 (P <0.01) and 0.7 0.2 mgldl(P < 0.05), respectively. Cyclic AMP levels in calvaria from rats with
metabolic acidosis and from control rats were not different. These data
suggest that mobilization of calcium from bone which occurs in
metabolic acidosis is due, in part, to increased bone resorption, which is
mediated by a cAMP-independent mechanism.
Effet de Ia colchicine et de Ia calcitonine sur Ia réponse calcemique a
l'acidose metabolique. Afin d'examiner le mécanisme responsable de Ia
stimulation de Ia mobilisation de calcium a partir de l'os dans l'acidose
métabolique, nous avons évalud l'effet de Ia colchicine et de la
calcitonine, deux bloqueurs de Ia résportion osseuse a mediation
cellulaire, sur Ia reponse calcémique a l'acidose métabolique aigue chez
des rats thyroparathyroidectomisés. Une acidose metabolique d'une
durée de 16 heures induite par administration de NH4CI a conduit a une
élévation significative du calcium serique de 1,2 a 1,9 mgldl. L'adminis-
tration de coichicine ou de calcitonine a entrainé une diminution du
calcium sérique de 1,1 0,2 (P < 0,01) et de 0,7 0,2 mg/dl (P < 0,05),
respectivement. Les niveaux d'AMP cyclique dans les calvaria de rats
en acidose metabolique ou de rats contrôles n'étaient pas différents.
Ces données suggèrent que Ia mobilisation du calcium a partir de l'os
qui survient en acidose métabolique est dOe, en partie, a une augmenta-
tion de Ia resorption osseuse, qui est médiée par un mécanisme
indépendant du CAMP.
It has been generally accepted that metabolic acidosis is
associated with enhanced mobilization of calcium from bone,
but the underlying mechanism has not been clearly elucidated
[1, 2]. Since in vitro studies have demonstrated that the
skeleton is more soluble in the presence of a reduced pH [3], it
is possible that acidosis merely causes dissolution of the
skeleton. Alternatively, metabolic acidosis might stimulate cell-
mediated bone resorption by enhancing the secretion or the
action of parathyroid hormone (PTH) [4, 5] or directly by a
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PTH-independent mechanism [6]. An earlier study by Beck and
Webster [5] demonstrated that acute metabolic acidosis is
associated with a rise in serum calcium in the absence of PTH.
The present studies were performed to determine if the rise in
serum calcium with metabolic acidosis in the absence of PTH is
due, in part, to increased bone resorption, and if so, is the
increased bone resorption mediated via cyclic AMP.
Methods
Experiments were performed in 77 male Wistar rats weighing
150 to 200 g. All animals were fed rat chow (Ralston Purina, St.
Louis, Missouri) containing 1.2% calcium and 0.8% phospho-
rus. In studies in which thyroparathyroidectomized (TPTX) rats
were utilized, the glands were extirpated by blunt dissection at
least 48 hr before study. Adequacy of TPTX was demonstrated
by a fall in serum calcium by at least 2 mgldl.
Protocol I. To evaluate whether or not short-term metabolic
acidosis was associated with an increment in serum calcium in
the absence of PTH, we used the following methods. TPTX rats
were given free access to distilled water, 1.8% NH4CI, or 0.9%
NaCI: The latter two groups were gavaged at the outset with 6
to 8 ml of either 1.8% NH4C1 or 0.9% NaCI, respectively.
Fourteen to sixteen hours later blood was obtained from the tail
vein for measurement of serum calcium. The animals were then
anesthetized with pentobarbital, 35 mg/kg, i.p., and blood was
obtained from the abdominal aorta for the measurement of pH
and Pco2.
Protocol II. To examine the effect of coichicine or calcitonin
on serum calcium levels in rats with intact thyroid and parathy-
roid glands, colchicine (Eli Lilly Co., Indianapolis, Indiana), 0.2
mg/100 g body weight (i.p.), or salmon calcitonin (Armour,
Scottsdale, Arizona), 60 mU/100 g body weight (s.c.), was
administered to rats with intact thyroid and parathyroid glands.
Blood was obtained from tail vein before and 4 (colchicine) or 2
hr (calcitonin) after one of these agents was administered. The
doses of these agents and the time of blood sampling have been
demonstrated previously to be associated with a significant
decrement in serum calcium [7, 8].
Protocol III. To determine if colchicine or calcitonin would
modify the increment in serum calcium produced by metabolic
acidosis, TPTX rats were gavaged with 6 to 8 ml of 1.8% NH4C1
and then allowed free access to 1.8% NH4CI as drinking water
as described in Protocol I. Fourteen to sixteen hours later, rats
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Fig. 1. Effect on serum calcium in TPTX rats fed with distilled water(0—0), 0.9% saline (—•), or1.8% NH4CI (A—A). Points connected
by a line represent values in the same animal. Horizontal lines denote
the mean values.
were injected with either coichicine, 0.2 mg/100 g body weight,
in 0.9% NaC1 as a vehicle or vehicle alone in a volume of 0.5 to
0.9 ml, i.p., or calcitonin, 60 mU/l0O g body weight in 0.9%
NaCl, vehicle alone, s.c. Thirty minutes later they were ga-
vaged again with 6 to 8 ml 1.8% NH4C1. Blood was obtained
from the tail vein before and 4 hr alter receiving intraperitoneal
colchicine or saline, and before and 2 hr after receiving subcuta-
neous calcitonin or saline. Arterial blood was analyzed for pH
and Pco2 as described above.
Protocol IV. To determine whether or not metabolic acidosis
is associated with increased bone cAMP levels, metabolic
acidosis was induced for 4 mm or 16 hr in TPTX rats in the
following manner. For the 4-mm acidosis studies, rats were
anesthetized with pentobarbital and the femoral artery was
catheterized for blood sampling and the jugular vein for admin-
istration of acid or saline. A bolus (0.5 ml) of 0.1 N HC1 was
infused over 30 sec followed by a constant infusion of 0.1 N HC1
over the subsequent 3.5 mm via the jugular vein at a rate
designed to reduce plasma pH to 6.9 to 7.2 and maintain it at
that level for 3.5 mm. The total volume of acid infused was 4 to
5 ml. Control rats for this group were given an equivalent
volume of 0.9% NaCI at the same rate. At 4 mm after the
initiation of acid or saline infusion, rats were decapitated and
the calvaria were processed for cyclic AMP determination as
described below. In the studies of 16-hr metabolic acidosis,
animals were gavaged with 6 to 8 ml of 1.8% NH4CI or distilled
water both 16 and 4 hr prior to sacrifice. The rats were
anesthetized with pentobarbital, and the femoral artery and
jugular vein were catheterized as previously described. Rats
were then given 0.5 ml 0.9% NaC1 i.v. over 20 sec. An
additional group of nonacidotic control rats were given PTH
(synthetic bovine 1-34 N-terminus amino acids, Beckman, Palo
Alto, California), 20 UIlOO g body weight, in 0.5 ml of 0.9%
NaCl i.v. over 20 sec. Two minutes alter receiving an injection
of saline or PTH, rats were decapitated and the calvaria were
processed for cyclic AMP determination as described below.
Table 1. Plasma conposition in colchicine and calcitonin-treated rats
and their controlsa
N pH
HCO3
mEqiliter
Creatinine
mg/dl
Pi
mg/dl
Coichicine 7 7.24 0.03 11.7 0.2 0.2 0.02 11.6 0.4
Saline control 8 7.21 0.02 13.3 0.5 0.2 0.02 11.6 0.7
Calcitonin 5 7.10 0.05 8.6 0.4 0.2 0.02 13.3 0.5
Saline control 7 7.00 0.03 8.0 0.5 0.2 0.03 12.1 0.4
a Values are the means SEM.
Analytical methods
Plasma bicarbonate was determine from the pH and Pco2
which were measured on a blood gas analyzer (IL-2l3, Instru-
mentation Laboratories, Lexington, Massachusetts) utilizing
the Henderson-Has selbalch equation with a pK of 6.1 and
solubility coefficient of 0.0301. Serum calcium was measured by
atomic absorption spectrophotometry (Perkin Elmer Model
303, Perkin Elmer Corp., Norwalk, Connecticut), serum inor-
ganic phosphate by the malachite green micromethod [9], and
serum creatinine by a creatinine analyzer (Beckman Instru-
ments, Fullerton, California). Cyclic AMP content of calvaria
was measured using methods described previously from our
and other laboratories [10, 11] with minor modifications. In
brief, immediately after decapitation calvaria were rapidly
dissected free of connective tissues in ice-cold 0.9% NaCl and
frozen in dry ice-acetone. The entire procedure from decapita-
tion to freezing of the calvaria required less than 30 sec. The
calvana were weighed and then immediately placed in 2.0 ml of
5% trichloroacetic acid (TCA) and homogenized using a homog-
enizer (Polytron, Brinkman Instruments, Westbury, New
York). The homogenizer was rinsed with 2.0 ml TCA, and the
rinse was combined with the extract. After centrifugation at
x2,000g for 10 mm, a 2.0-ml aliquot of the supernatant was
transferred to a glass tube; tracer amounts (5,000 cpm) of 3H-
cAMP were then added. TCA in the extract was removed by
washing the extract three times with five volumes of ether
saturated with water. The extract was purified through a 7 x 60
mm column (Dowex 60 W-X2, 200 to 400 mesh, BioRad Lab,
Richmond, California). The fraction containing cyclic AMP was
lyophilized, resuspended in 500 l of 50 m sodium acetate
buffer, pH 6.2, and aliquots were measured in duplicate for 3H-
cAMP for recovery and for cyclic AMP using radioim-
munoassay [121. Results are expressed, after correction for
recovery, as picomoles of cyclic AMP per 100 milligrams of wet
weight calvaria. Recovery of 3H-cAMP was 60 to 80%.
All values presented represent the mean SEM. Statistical
analysis was performed utilizing Student's t test as paired or
nonpaired when appropriate. Unless otherwise indicated, P
values less than 0.01 were considered significant.
Results
There was no difference in the results obtained in rats fed
either distilled water or sodium chloride, therefore, the data
were combined for statistical analysis. Plasma pH and bicar-
bonate concentration in rats fed ammonium chloride, 7.17
0.03 and 11.6 0.2 mEq/liter, respectively, were lower than in
rats fed distilled water or saline, 7.42 0.02 and 22.7 0.8
mEq/liter, respectively. Figure 1 depicts the effect of adminis-
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Fig. 2. Changes in serum calcium in response to the administration of
coichicine (left panel) and calcitonin (right panel) in rats with intact
thyroid and para thyroid glands. Points connected by a line represent
values in the same animal. Horizontal lines denote the means.
tration of ammonium chloride, water, or sodium chloride on
serum calcium. As is apparent metabolic acidosis led to a
significant rise in serum calcium which averaged 2.6 0.6
mg/dl, whereas, there was no significant change in serum
calcium in animals given sodium chloride or water.
Plasma pH, bicarbonate, and creatinine, in the groups fed
ammonium chloride are shown in Table 1. The ammonium
chloride led to a marked fall in plasma pH and bicarbonate
concentration in all groups. There was no significant difference
in plasma pH, bicarbonate, creatinine, and phosphate between
the groups given either colchicine or calcitonin and the respec-
tive control rats.
Figure 2 shows the change in serum calcium in intact rats
given colchicine or calcitonin. Administration of colchicine led
to a fall in serum calcium which averaged 2.0 0.4 mgldl.
Similarly, administration of calcitonin led to a striking fall in
serum calcium which averaged 3.9 0.2 mg/dl.
Figure 3 depicts the effect of administration of colchicine or
saline on the increment in calcium noted with metabolic acido-
sis. Fourteen hours after the initial acid feeding, the rise in
serum calcium in the colchicine-treated group and its saline
control, 1.2 0.2 and 1.9 0.4 mg/dl, respectively, was not
different. However, the subsequent administration of coichicine
30 mm before the second acid feeding caused a decrement in
serum calcium, which averaged 1.1 0.2 mgldl, whereas the
administration of saline had no significant effect on serum
calcium levels.
Figure 4 shows the effect of administration of calcitonin on
the calcemic response to acid feedings. Fourteen hours after
acid feeding, serum calcium had risen by a similar degree in the
calcitonin-treated group and its saline control, 1.5 0.3 and 1.7
0.4 mg/dl, respectively. However, administration of calcito-
nm prior to the second acid feeding led to a decrement in serum
calcium which averaged 0.7 0.2 mgldl (P < 0,05). By
contrast, administration of saline did not reduce serum calcium
at all.
Table 2 shows the acid-base parameters and serum calcium in
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Fig. 3. Modification of acidosis-induced increments in serum calcium
by colchicine (left panel) and the lack of effect of saline (right panel).
Individual data points connected by a line represent data in the same
animal. Horizontal bars are the means. See Results for details.
rats with 16-hr acidosis, nonacidotic control rats, and nonacido-
tic control rats given PTH in whom calvaria cAMP was
measured. Plasma bicarbonate concentration and plasma pH
were lower in acidotic rats than in control rats given saline or
PTH. Serum calcium was higher in acidotic than control
animals given saline or PTH. Figure 5 depicts cyclic AMP levels
in the calvaria of control rats, rats with 4-mm or 16-hr acidosis
and control rats given PTH. Basal cyclic AMP levels in rat
calvaria with metabolic acidosis of 16 hr and the control rats
were not different averaging 5.3 0.7 and 6.6 0.9 pmoles/lOO
mg wet weight, respectively. Furthermore, cyclic AMP levels
in rat calvaria with metabolic acidosis for 4 mm were similar to
that noted in saline control rats, 9.3 1.8 and 10.5 2.0
pmoles/100 mg wet weight, respectively. By contrast, adminis-
tration of PTH to nonacidotic control rats led to a marked rise in
cyclic AMP in calvaria which averaged 28.8 3.0 pmoles/l00
mg wet weight.
Discussion
The present study demonstrated that short-term metabolic
acidosis is associated with an increment in serum calcium in the
absence of PTH as previously reported by Beck and Webster
[51 and that the increment in serum calcium with metabolic
acidosis is largely abolished by the administration of either
calcitonin or coichicine. Although we did not measure ionized
calcium in the present study, it is very likely that increments in
total serum calcium in metabolic acidosis reflect a rise in
ionized calcium as reported previously [5].
It has been well established that the hypocalcemic actions of
calcitonin and coichicine are mediated by inhibition of bone
resorption [7, 8]. In addition to inhibiting bone resorption,
calcitonin may lower serum calcium by its effect on calcium
uptake by the bone [13]. Colchicine, however, has no signifi-
cant effect on calcium uptake by the bone [71. Therefore, the
qualitatively similar fall in serum calcium in response to both
agents suggests that the rise in serum calcium with metabolic
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Fig. 4. Modification of acidosis-induced increments in serum calcium
by calcitonin (left panel) and the lack of effect of saline (right panel).
See the Figure 3 legend for explanation.
acidosis occurs, in part, as a consequence of increased bone
resorption.
The results of these studies, however, do not exclude a role
for direct dissolution of bone by acidosis. In fact, in the animals
receiving calcitonin, serum calcium did not return to levels
noted before acid feeding, observations which are consistent
with acidosis contributing to the rise in serum calcium, in part,
by dissolution of the skeleton. In vitro studies have shown that
the solubility of bone is greater with a low pH [3, 141, suggesting
that acidosis can cause the release of calcium from bone by the
dissolution of mineral. Thus, it is likely that both cell-mediated
bone resorption and direct dissolution of the skeleton contrib-
ute to the mobilization of calcium from bone during metabolic
acidosis. A recent in vitro study by Geisser et al [15] also
showed that an acidemic pH increased 45Ca release from bone
by both demineralization and cell-mediated resorption.
Metabolic acidosis could increase intestinal absorption of
calcium or reduce urinary calcium excretion thereby contribut-
ing to a rise in serum calcium. When measured in separate
experiments, urinary calcium excretion was substantially high-
er in rats with 16-hr acidosis than in control rats, 2.1 0.4 and
0.6 0.1 mg/16 hr, respectively (P < 0.02). This higher urinary
calcium excretion in acidosis would favor a fall and not a rise in
serum calcium. Therefore, alterations in urinary calcium excre-
tion are unlikely to explain the increment in serum calcium with
acidosis. We did not determine intestinal absorption of calcium
in the present study. Therefore, we cannot exclude the possibil-
ity that increased intestinal calcium absorption could contribute
to a rise in serum calcium in acidosis. However, the majority of
published studies show that acidosis either has no effect [16] or
decreases intestinal calcium absorption [17, 18]. Moreover, a
rise in ionized calcium with short-term metabolic acidosis was
seen even when the gastrointestinal tract and kidneys were
removed [5].
Although considering that metabolic acidosis may stimulate
cell-mediated resorption without PTH, the question of how this
might be accomplished remains to be answered. Two factors
pH
HCO3
mEq/liter
Calcium
mgldl
16-hr Acidosis 7.00 0.03 7.3 0.4 8.9 0.5
Control rats 7.44 0.02b 24.5 0.9" 5.4 0.5"
Control rats with PTH 7.44 0.04" 23.3 0.4b 5.1 0.6"
.
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Control Acidosis Control Acidosis
Fig. 5. Cyclic AMP levels in calvaria of rats with metabolic acidosis for
4 mm, 16 hr, and in nonacidotic controls given PTH. Each point
represents the value in one animal. Horizontal lines denote the mean.
See Results for details.
known to stimulate cell-mediated bone resorption independent
of PTH are 1,25(OH)2D and hypophosphatemia [19, 20]. Al-
though we did not measure plasma concentrations of
1 ,25(OH)2D, previous studies have demonstrated that metabol-
ic acidosis is associated with either a decrease or no change in
the plasma level of 1,25(OH)2D [21—23]. Moreover, serum
phosphate concentrations in the TPTX rats of the present study
were not low; therefore, it is unlikely that either increased
levels of I ,25(OH)2D or hypophosphatemia contribute to the
increased bone resorption.
It is well accepted that PTH stimulates bone resorption via
cyclic AMP [11, 24—261. Recently, Martin et al [61 showed that
an acute reduction in the pH of the perfusate in an isolated
perfused bone preparation caused an increase in release of
cyclic AMP into the perfu sate of similar magnitude to that noted
with a PTH infusion. These investigators suggest that acidemia
might stimulate cell-mediated bone resorption directly by aug-
menting cyclic AMP production by bone cells. In the present
study, increased cell-mediated bone resorption in response to
metabolic acidosis was observed without increased accumula-
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Table 2. Acid-base parameters and serum calcium in rats with 16-hr
metabolic acidosis and nonacidotic control rats with and without PTH
administrationa
a Values are the means SEM.
b P < 0.01 vs. 16-hr acidosis.
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tion of cyclic AMP in bone. These data suggest that the
enhanced bone resorption in short-term metabolic acidosis is
not mediated via cyclic AMP. It might be argued that the
exposure of bone to acidosis was of insufficient duration tp
induce an increase in cyclic AMP, but we feel this is unlikely.
Thus, cyclic AMP in calvaria was measured both at 16-hr
acidosis, when the caicemic response to metabolic acidosis was
noted, and after a few minutes of exposure to an acidemic
milieu. PTH and other hormones have been shown to increase
the accumulation of cyclic AMP in calvaria within 1 to 2 mm.
Therefore, if acidosis significantly increased cyclic AMP accu-
mulation in bone, this effect should have been observed within
the time frame of our study. In addition,,our data confirmed that
the administration of PTH to nonacidotic rats resulted in a
marked increment in cyclic AMP accumulation in calvaria
within 2 mm.
Bone disease occurring in chronic acidotic states has been
attributed to: (1) altered vitamin D metabolism; (2) increased
circulating levels or enhanced action of PTH on bone; and (3)
direct dissolution of the skeleton. If the enhanced PTH-inde-
pendent cell-mediated bone resorption observed in acute acido-
sis is also found in chronic acidosis, it may contribute to the
bone disease in this disorder.
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